These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7603491)

  • 1. [Isolation of a group of hybrid proteins consisting of tumor necrosis factor alpha and thymosin alpha 1].
    Shmelev VA; Bunina ZF; Kudriavtseva TIu; Zinchenko EV; Boldyreva EF; Korobko VG
    Mol Gen Mikrobiol Virusol; 1995; (1):9-14. PubMed ID: 7603491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Synthesis of an artificial gene coding for thymosin alpha1 and its expression in Escherichia coli as a hybrid with human tumor necrosis factor].
    Korobko VG; Boldyreva EF; Filippov SA; Berkova NP; Dobrynin VN; Shmelev VA; Popov SG; Evsegneev SI; Nosova LIu
    Bioorg Khim; 1992 May; 18(5):646-59. PubMed ID: 1417992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fusion expression of human thymosin alpha 1 in Escherichia coli].
    Xiu ZY; Yu Y; Chen CQ
    Sheng Wu Gong Cheng Xue Bao; 2002 Sep; 18(5):541-5. PubMed ID: 12561195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production in Escherichia coli of human thymosin beta 4 as chimeric protein with human tumor necrosis factor.
    Tsuji Y; Kitahara-Tanabe N; Noguchi K; Gatanaga T; Mizuno D; Soma G
    Biochem Int; 1989 Mar; 18(3):501-8. PubMed ID: 2669759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of thymosin alpha1 via non-enzymatic acetylation of the recombinant precursor.
    Esipov RS; Stepanenko VN; Beyrakhova KA; Muravjeva TI; Miroshnikov AI
    Biotechnol Appl Biochem; 2010 May; 56(1):17-25. PubMed ID: 20408810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of soluble human thymosin alpha 1 in Escherichia coli.
    Chen PF; Zhang HY; Fu GF; Xu GX; Hou YY
    Acta Biochim Biophys Sin (Shanghai); 2005 Feb; 37(2):147-51. PubMed ID: 15685373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and activity analysis of interferonalpha-con and thymosin-alpha1].
    Liu X; Liu F; Li B; Zhou H; Wang Q
    Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1168-73. PubMed ID: 18837390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and expression of a new fusion protein, thymosin alpha1-cBLyS, E. coli.
    Shen Q; Tian R; Ma W; Yuan Q; Gong Y
    Biotechnol Lett; 2005 Feb; 27(3):143-8. PubMed ID: 15717121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunobiologic characteristics of hybrid proteins consisting of tumor necrosis factor alpha and thymosin alpha 1].
    Shmelev VA; Khromykh LM; Dudich EI; Sheviakova LIa; Gorbatova EA; Galaktionov VG
    Vestn Ross Akad Med Nauk; 1994; (6):55-61. PubMed ID: 7522706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic and antitumor activity of a recombinant tumor necrosis factor-B1(Fv) fusion protein on LeY antigen-expressing human cancer cells.
    Scherf U; Benhar I; Webber KO; Pastan I; Brinkmann U
    Clin Cancer Res; 1996 Sep; 2(9):1523-31. PubMed ID: 9816329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-mediation of tumor targeting human recombinant tumor necrosis factor-α fusion protein.
    Ren H; Shao X; Zeng L; Wang F; Huang DN; Hou G
    Mol Med Rep; 2015 Aug; 12(2):2035-42. PubMed ID: 25891416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of human and mouse recombinant alpha-fetoproteins expressed in Escherichia coli.
    Boismenu R; Semeniuk D; Murgita RA
    Protein Expr Purif; 1997 Jun; 10(1):10-26. PubMed ID: 9179285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Purification of recombinant proteins with an example of tumor necrosis factor thymosin-alpha1].
    Fedorov TV; Korobov VI; Nazarov VG; Smolkina AE; Shmelev VA
    Prikl Biokhim Mikrobiol; 2010; 46(2):243-7. PubMed ID: 20391771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of shuttle expression vector and expression of thymosin alpha 1 in Synechococcus sp. PCC7942].
    Zhang J; Qin Y; Ouyang Q; Xu H; Zhou KF; Liu RH; Lou SL
    Shi Yan Sheng Wu Xue Bao; 2003 Feb; 36(1):1-4. PubMed ID: 12751202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant thymosin alpha1].
    Esipov RS; Gurevich AI; Stepanenko VN; Chupova LA; Chuvikovskiĭ DV; Miroshnikov AI
    Bioorg Khim; 2004; 30(5):481-6. PubMed ID: 15562968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prokaryotic-expressed porcine IFNα1-THYα1 fusion proteins exert IFN and THY activities in vitro.
    Wang N; Liu S; Shi H; Zhang P; Cheng Y; Su D; Lu C; Yu H; Hao L
    Biologicals; 2015 Jul; 43(4):225-31. PubMed ID: 26073788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene.
    Wetzel R; Heyneker HL; Goeddel DV; Jhurani P; Shapiro J; Crea R; Low TL; McClure JE; Thurman GB; Goldstein AL
    Biochemistry; 1980 Dec; 19(26):6096-104. PubMed ID: 7008828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and analysis of thymosin alpha1 concatemer in Escherichia coli.
    Chen Y; Zhao L; Shen G; Cui L; Ren W; Zhang H; Qian H; Tang K
    Biotechnol Appl Biochem; 2008 Jan; 49(Pt 1):51-6. PubMed ID: 17523920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overproduction in Escherichia coli, purification and properties of human prothymosin alpha.
    Evstafieva AG; Chichkova NV; Makarova TN; Vartapetian AB; Vasilenko AV; Abramov VM; Bogdanov AA
    Eur J Biochem; 1995 Aug; 231(3):639-43. PubMed ID: 7649163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.